These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 1712335)

  • 1. Studies on the mechanism of arterial vasodilation produced by the novel antihypertensive agent, carvedilol.
    Nichols AJ; Gellai M; Ruffolo RR
    Fundam Clin Pharmacol; 1991; 5(1):25-38. PubMed ID: 1712335
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The interaction of the enantiomers of carvedilol with alpha 1- and beta 1-adrenoceptors.
    Nichols AJ; Sulpizio AC; Ashton DJ; Hieble JP; Ruffolo RR
    Chirality; 1989; 1(4):265-70. PubMed ID: 2577144
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro pharmacologic profile of the novel beta-adrenoceptor antagonist and vasodilator, carvedilol.
    Nichols AJ; Sulpizio AC; Ashton DJ; Hieble JP; Ruffolo RR
    Pharmacology; 1989; 39(5):327-36. PubMed ID: 2575762
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The pharmacology of carvedilol.
    Ruffolo RR; Gellai M; Hieble JP; Willette RN; Nichols AJ
    Eur J Clin Pharmacol; 1990; 38 Suppl 2():S82-8. PubMed ID: 1974511
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Single and repeated doses of the vasodilator/beta-adrenergic antagonist, carvedilol, block cirazoline- and isoproterenol-mediated hemodynamic responses in the conscious rat.
    Smith EF; Slivjak MJ; Gagnon R
    Cardiovasc Drugs Ther; 1992 Oct; 6(5):499-504. PubMed ID: 1360255
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of the adrenoceptor antagonistic and antihypertensive activity of oral amosulalol, a combined alpha- and beta-adrenoceptor antagonist, in hypertensive rats.
    Inagaki O; Sudoh K; Shibasaki M; Nakagawa C; Honda K
    J Cardiovasc Pharmacol; 1994 Nov; 24(5):794-802. PubMed ID: 7532758
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of the mechanism underlying the vasodilator action of carvedilol in pithed spontaneously hypertensive rats.
    Hashimoto H; Tanaka M; Kanda A; Akashi A
    Drugs; 1988; 36 Suppl 6():31-6. PubMed ID: 2908302
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vasodilating mechanism and response to physiological pressor stimuli of acute doses of carvedilol compared with labetalol, propranolol and hydralazine.
    Tomlinson B; Bompart F; Graham BR; Liu JB; Prichard BN
    Drugs; 1988; 36 Suppl 6():37-47. PubMed ID: 2908303
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacodynamic profile of carvedilol.
    van Zwieten PA
    Cardiology; 1993; 82 Suppl 3():19-23. PubMed ID: 8106159
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Carvedilol blockade of alpha1- and beta-adrenoceptor induced inotropic responses in rats with congestive heart failure.
    Qvigstad E; Sjaastad I; Bøkenes J; Schiander I; Solberg L; Sejersted OM; Osnes JB; Skomedal T
    Eur J Pharmacol; 2005 May; 516(1):51-9. PubMed ID: 15916756
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of pertussis toxin treatment on postjunctional alpha-1 and alpha-2 adrenoceptor function in the cardiovascular system of the pithed rat.
    Nichols AJ; Motley ED; Ruffolo RR
    J Pharmacol Exp Ther; 1989 Apr; 249(1):203-9. PubMed ID: 2468761
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activation of capsaicin-sensitive sensory neurons by carvedilol, a nonselective beta-blocker, in spontaneous hypertensive rats.
    Okajima K; Harada N; Uchiba M; Isobe H
    J Pharmacol Exp Ther; 2004 May; 309(2):684-91. PubMed ID: 14764656
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Features of the acute hypotensive action of carvedilol and its ameliorating effect on myocardial ischemia.
    Hashimoto H; Kanda A; Hubo H; Tanaka M
    J Cardiovasc Pharmacol; 1991; 18 Suppl 4():S22-8. PubMed ID: 1721975
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Autonomic and antihypertensive activity of oral amosulalol (YM-09538), a combined alpha- and beta-adrenoceptor blocking agent in conscious rats.
    Honda K; Takenaka T; Shiono K; Miyata-Osawa A; Nakagawa C
    Jpn J Pharmacol; 1985 May; 38(1):31-41. PubMed ID: 2862302
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alpha 1-blocking properties of carvedilol during acute and chronic administration.
    Giannattasio C; Cattaneo BM; Seravalle G; Carugo S; Mangoni AA; Grassi G; Zanchetti A; Mancia G
    J Cardiovasc Pharmacol; 1992; 19 Suppl 1():S18-22. PubMed ID: 1378144
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adrenoceptor-blocking activity and cardiohemodynamic effects of carvedilol in animals.
    Kawada T; Ishibashi T; Nakazawa M; Satoh S; Imai S
    J Cardiovasc Pharmacol; 1990 Jul; 16(1):147-53. PubMed ID: 1696657
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-hypertension effect of vanylidilol: a phenylaldehyde alpha/beta-adrenoceptor blocker with endothelium-dependent and K+ channels opening-associated vasorelaxant activities.
    Chiu CC; Wu JR; Lee CH; Liou SF; Dai ZK; Chen IJ; Yeh JL
    Pharmacology; 2004 Mar; 70(3):140-51. PubMed ID: 14752234
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Existence of spare alpha 1-adrenoreceptors, but not alpha 2-adrenoreceptors, for respective vasopressor effects of cirazoline and B-HT 933 in the pithed rat.
    Ruffolo RR; Yaden EL
    J Cardiovasc Pharmacol; 1984; 6(6):1011-9. PubMed ID: 6084756
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical pharmacology of carvedilol.
    Tomlinson B; Prichard BN; Graham BR; Walden RJ
    Clin Investig; 1992; 70 Suppl 1():S27-36. PubMed ID: 1350481
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Carvedilol blockade of rat myocardial alpha1-adrenoceptors.
    Qvigstad E; Osnes JB; Sandnes D; Schiander I; Bøkenes J; Sjaastad I; Skomedal T
    Eur J Pharmacol; 2003 Nov; 481(1):83-9. PubMed ID: 14637179
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.